alexa
Reach Us +44-1202-068036
Advantage of publishing in Journal of Clinical and Experimental Pharmacology | List of High Impact Articles | PPts | Journals | Videos
Journal of Clinical & Experimental Pharmacology

ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology

Advantage of publishing in Journal of Clinical and Experimental Pharmacology

Search results for
Advantage of publishing in Journal of Clinical and Experimental Pharmacology

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Relevant Topics

  • It is an open access journal which means that your paper is available to anyone around the globe to download for free directly from the Omics website.
  • We are an electronic journal and there are no limits on the number or size of the papers we can publish so, your paper will not be rejected due to lack of space unlike many traditional journals.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Journal of Clinical and Experimental Pharmacology generally peer review is complete within 3-6 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 8 weeks for a final decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

Advantage of publishing in Journal of Clinical and Experimental Pharmacology

Expert PPTs

Speaker PPTs